Patents by Inventor Roni Oren

Roni Oren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for the treatment of insulin-associated medical conditions
    Patent number: 9301981
    Abstract: A method of increasing insulin content in a pancreatic beta cell is disclosed. The method comprising expressing in the pancreatic beta cell an exogenous polynucleotide encoding at least one microRNA or a precursor thereof, wherein the microRNA is selected from the group consisting of miR-15, miR-16, miR-24, miR-26, miR-27, miR-29, miR-30, miR-129, miR-141, miR-148, miR-182, miR-200, miR-376 and Let-7, thereby increasing the insulin content in the pancreatic beta cell.
    Type: Grant
    Filed: January 4, 2015
    Date of Patent: April 5, 2016
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Eran Hornstein, Tal Melkman-Zehavi, Roni Oren
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS
    Publication number: 20150125433
    Abstract: A method of increasing insulin content in a pancreatic beta cell is disclosed. The method comprising expressing in the pancreatic beta cell an exogenous polynucleotide encoding at least one microRNA or a precursor thereof, wherein the microRNA is selected from the group consisting of miR-15, miR-16, miR-24, miR-26, miR-27, miR-29, miR-30, miR-129, miR-141, miR-148, miR-182, miR-200, miR-376 and Let-7, thereby increasing the insulin content in the pancreatic beta cell.
    Type: Application
    Filed: January 4, 2015
    Publication date: May 7, 2015
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Eran HORNSTEIN, Tal MELKMAN-ZEHAVI, Roni OREN
  • Methods and compositions for the treatment of insulin-associated medical conditions
    Patent number: 8951983
    Abstract: A method of increasing insulin content in a pancreatic beta cell is disclosed. The method comprising expressing in the pancreatic beta cell an exogenous polynucleotide encoding at least one microRNA or a precursor thereof, wherein the microRNA is selected from the group consisting of miR-15, miR-16, miR-24, miR-26, miR-27, miR-29, miR-30, miR-129, miR-141, miR-148, miR-182, miR-200, miR-376 and Let-7, thereby increasing the insulin content in the pancreatic beta cell.
    Type: Grant
    Filed: October 10, 2011
    Date of Patent: February 10, 2015
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Eran Hornstein, Tal Melkman-Zehavi, Roni Oren
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS
    Publication number: 20130209440
    Abstract: A method of increasing insulin content in a pancreatic beta cell is disclosed. The method comprising expressing in the pancreatic beta cell an exogenous polynucleotide encoding at least one microRNA or a precursor thereof, wherein the microRNA is selected from the group consisting of miR-15, miR-16, miR-24, miR-26, miR-27, miR-29, miR-30, miR-129, miR-141, miR-148, miR-182, miR-200, miR-376 and Let-7, thereby increasing the insulin content in the pancreatic beta cell.
    Type: Application
    Filed: October 10, 2011
    Publication date: August 15, 2013
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Eran Hornstein, Tal Melkman-Zehavi, Roni Oren